Christopher J. Miller

About

Christopher J. Miller, M.D., is the Louis A. Duhring, MD Endowed Professor in Dermatology at the University of Pennsylvania. He serves as the Director of Dermatologic Surgery, the Director of the Mohs Laboratory, and the Director of the Fellowship in Procedural Dermatology at the Hospital of the University of Pennsylvania. His clinical expertise includes Mohs micrographic surgery, reconstructive surgery, skin cancer, basal cell cancer, squamous cell cancer, melanoma, and cutaneous oncology, with a focus on service excellence. His research expertise encompasses Mohs micrographic surgery, reconstructive surgery, skin cancer, and surgical education. Dr. Miller is actively involved in leadership roles within the university's melanoma and skin cancer initiatives, including the Penn Dermatology Oncology Center and the Melanoma Leadership Group at the Abramson Cancer Center.

Research topics

• Biology
• Virology
• Immunology
• Medicine
• Dermatology

Selected publications

• SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques

  Nature Communications · 2021-01-22 · 88 citations

  articleOpen access

  Abstract CD4 T follicular helper (T fh ) cells are important for the generation of durable and specific humoral protection against viral infections. The degree to which SARS-CoV-2 infection generates T fh cells and stimulates the germinal center (GC) response is an important question as we investigate vaccine induced immunity against COVID-19. Here, we report that SARS-CoV-2 infection in rhesus macaques, either infused with convalescent plasma, normal plasma, or receiving no infusion, resulted i…

  PublisherOA PDFDOI

• Management of primary skin cancer during a pandemic: Multidisciplinary recommendations

  Cancer · 2020-06-01 · 87 citations

  reviewOpen accessSenior author

  During the coronavirus disease 2019 (COVID-19) pandemic, providers and patients must engage in shared decision making regarding the pros and cons of early versus delayed interventions for localized skin cancer. Patients at highest risk of COVID-19 complications are older; are immunosuppressed; and have diabetes, cancer, or cardiopulmonary disease, with multiple comorbidities associated with worse outcomes. Physicians must weigh the patient's risk of COVID-19 complications in the event of exposur…

  PublisherOA PDFDOI

• The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters

  PLoS Pathogens · 2022-02-10 · 41 citations

  articleOpen accessSenior authorCorresponding

  As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe disease and evade vaccine-induced immunity is rapidly assessed in humans and studied in animal models. In early January 2021, a novel SARS-CoV-2 variant designated B.1.429 comprising 2 lineages, B.1.427 and B.1.429, was originally detected in California (CA) and it was shown to have enhanced infectivity in vitro and decreased antibody neutralization by plasma from convalescent patients and vaccin…

  PublisherOA PDFDOI

• Merkel Cell Carcinoma

  Dermatologic Clinics · 2022-10-28 · 25 citations

  review
  PublisherDOI

• Evaluation and diagnosis of longitudinal melanonychia: A clinical review by a nail expert group

  Journal of the American Academy of Dermatology · 2025-02-27 · 13 citations

  reviewOpen access
  PublisherOA PDFDOI

Recent grants

• NIH Grant R01AI051239

  NIH · $3.8M · 2006

• NIH Grant R01AI094620

  NIH · $3.5M · 2017

• NIH Grant P01AI066314

  NIH · $17.0M · 2010

Frequent coauthors

• Michael M. Lederman

  Case Western Reserve University

  89 shared

• Zhong-Min Ma

  72 shared

• Marty S. Springer

  Merck & Co., Inc., Rahway, NJ, USA (United States)

  72 shared

• Yichuan Wang

  University of Sheffield

  68 shared

• Kristina Abel

  University of North Carolina at Chapel Hill

  66 shared

• Ronald S. Veazey

  Tulane University

  65 shared

• John P. Moore

  Cornell University

  65 shared

• Dean H. Hamer

  64 shared

Similar researchers at University of Pennsylvania

• John Q. Trojanowskih-296
• Craig B. Thompsonh-277
• Daniel J Raderh-236